Diagnostic performance of noncultural methods for central nervous system aspergillosis

Ling-Hong Zhou1, Rong-Sheng Zhu1, Yan-Ping Gong2

  • 1Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.

Mycoses
|December 15, 2022
PubMed
Abstract

Insights

Diagnosing central nervous system (CNS) aspergillosis is challenging. Combining cerebrospinal fluid (CSF) galactomannan (GM) testing with metagenomic next-generation sequencing (mNGS) improves diagnostic accuracy, particularly for encephalitis cases.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Neurology

Background:

  • Central nervous system (CNS) aspergillosis is a rare but often fatal infection.
  • Accurate and timely diagnosis of CNS aspergillosis remains a significant clinical challenge.

Purpose of the Study:

  • To evaluate the diagnostic performance of noncultural diagnostic methods for CNS aspergillosis.
  • To compare the efficacy of cerebrospinal fluid (CSF) galactomannan (GM) testing and metagenomic next-generation sequencing (mNGS) in diagnosing CNS aspergillosis.

Main Methods:

  • Retrospective analysis of pathologically confirmed rhinosinusitis patients who underwent CSF GM testing and mNGS.
  • Evaluation of CSF GM optical density index (ODI) at various cut-off values.
  • Comparison of diagnostic performance between individual tests and their combination, stratified by CNS aspergillosis presence and clinical manifestations.

Main Results:

  • Among 21 proven/probable cases, CSF GM was positive in 10, and mNGS in 5. Culture was positive in only one case.
  • The combination of CSF GM (ODI >0.7) and mNGS achieved the highest diagnostic performance with 61.9% sensitivity and 82.6% specificity.
  • Diagnostic sensitivity varied by clinical presentation, with the lowest in the abscess group (42.9%) and highest in encephalitis patients (77.8% sensitivity, 82.6% specificity) when using the combined approach.

Conclusions:

  • The combination of CSF GM testing and mNGS offers a valuable diagnostic strategy for CNS aspergillosis, especially in patients with fungal rhinosinusitis.
  • This combined approach demonstrates particular utility in diagnosing CNS aspergillosis presenting as encephalitis.